Picture of MindWalk Holdings logo

HYFT MindWalk Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-29.45%
3m+69.95%
6m+286.33%
1yr+145.41%
Volume Change (%)
10d/3m-6.54%
Price vs... (%)
52w High-42.08%
50d MA-7.78%
200d MA+106.59%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-94.72%
Return on Equity-105.08%
Operating Margin-136.87%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Apr 202630th Apr 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of MindWalk Holdings EPS forecast chart

Profile Summary

MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Directors

Last Annual
April 30th, 2025
Last Interim
April 30th, 2025
Incorporated
September 2nd, 2016
Public Since
January 30th, 1987
No. of Employees
102
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
46,157,312

HYFT Share Price Performance

Upcoming Events for HYFT

Immunoprecise Antibodies Ltd Annual Shareholders Meeting

Q2 2026 Immunoprecise Antibodies Ltd Earnings Release

Similar to HYFT

Picture of 60 Degrees Pharmaceuticals logo

60 Degrees Pharmaceuticals

us flag iconNASDAQ Capital Market

Picture of Abeona Therapeutics logo

Abeona Therapeutics

us flag iconNASDAQ Capital Market

Picture of Adaptimmune Therapeutics logo

Adaptimmune Therapeutics

us flag iconNASDAQ Capital Market

Picture of Akari Therapeutics logo

Akari Therapeutics

us flag iconNASDAQ Capital Market

Picture of Akebia Therapeutics logo

Akebia Therapeutics

us flag iconNASDAQ Capital Market

FAQ